Currently, the effects of 2.4 mg semaglutide once weekly are being explored in 1200 participants with biopsy-confirmed NASH in a Phase III clinical trial with a combined primary endpoint of resolution of NASH without worsening fibrosis, improvement in liver fibrosis without worsening of steatohepatitis, and time to first liver-related clinical event (NCT04822181) (see Table 2)
As healthcare continues to evolve, innovations like these remind us of the importance of combining clinical research, physician partnership, and patient-centered care to move kidney care forward
B12 is routinely sold in pharmacies, but prescription is needed
Even so, these products remain widely promoted online
While both blood sugar and weight loss regulators, Ozempic and Mounjaro are not the same medication
The Road Ahead for B12 and Autism Were still learning about the relationship between B12 and autism